US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

25.14

-1.3200-4.99%

Post-market: 24.65-0.4900-1.95%17:21 EST

Volume:58.00K

Turnover:1.40M

Market Cap:76.97M

PE:-1.69

High:26.95

Open:26.67

Low:21.61

Close:26.46

52wk High:54.29

52wk Low:5.51

Shares:3.06M

Float Shares:2.62M

Volume Ratio:2.20

T/O Rate:2.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-14.8358

EPS(LYR):-14.2710

ROE:-83.00%

ROA:-20.64%

PB:1.32

PE(LYR):-1.76

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PELTHOS THERAPEUTICS INC

Exchange:

AMEX

Establishment Date:

2002

Employees:

8

Office Location:

4020 Stirrup Creek Drive,Suite 110,Durham,North Carolina,United States

Website:

http://www.chromocell.com

Zip Code:

27703

Phone:

Fax:

- -

Introduction:

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Directors

Name

Position

Peter Greenleaf

Chairman of the Board and Director

Scott M. Plesha

Director,Chief Executive Officer and President

Ezra Friedberg

Director

Matthew Pauls

Director

Richard Baxter

Director

Richard Malamut

Director

Todd Davis

Director

Shareholders

Name

Position

Scott M. Plesha

Director,Chief Executive Officer and President

Francis Knuettel II

Chief Financial Officer, Secretary and Treasurer

Sai Rangarao

Chief Commercial Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PTHS/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":25.14,"timestamp":1764709200000,"preClose":26.46,"halted":0,"volume":58002,"hourTrading":{"tag":"盘后","latestPrice":24.65,"preClose":25.14,"latestTime":"17:21 EST","volume":12,"amount":298.249992,"timestamp":1764714119525},"delay":0,"floatShares":2623100,"shares":3061681,"eps":-14.835798,"marketStatus":"Post-Mkt","change":-1.32,"latestTime":"12-02 17:47:02 EST","open":26.67,"high":26.95,"low":21.61,"amount":1401982.9305719999,"amplitude":0.201814,"askPrice":35.81,"askSize":100,"bidPrice":24.65,"bidSize":44,"shortable":0,"etf":0,"ttmEps":-14.835798,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":26.46,"preHourTrading":{"tag":"盘前","latestPrice":27.49,"preClose":26.46,"latestTime":"09:28 EST","volume":6,"amount":164.95000199999998,"timestamp":1764685737598},"postHourTrading":{"tag":"盘后","latestPrice":24.65,"preClose":25.14,"latestTime":"17:21 EST","volume":12,"amount":298.249992,"timestamp":1764714119525},"volumeRatio":2.197145},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":2623100,"roa":"-20.64%","roe":"-83.00%","lyrEps":-14.271021,"volumeRatio":2.197145,"shares":3061681,"dividePrice":0,"high":26.95,"amplitude":0.201814,"preClose":26.46,"low":21.61,"week52Low":5.513,"pbRate":"1.32","psRate":"10.39","week52High":54.29,"institutionHeld":0,"latestPrice":25.14,"committee":-0.388889,"eps":-14.835798,"divideRate":0,"volume":58002,"delay":0,"ttmEps":-14.835798,"open":26.67,"prevYearClose":6.41,"prevWeekClose":28.4,"prevMonthClose":28.4,"prevQuarterClose":28,"fiveDayClose":27.53,"twentyDayClose":34.21,"sixtyDayClose":32.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1764306000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2025-12-01","current":-1.783524,"percent":0.580952,"low":-12.702408,"twenty":-11.1077,"median":-7.894967,"eighty":-1.793992,"high":-1.189404,"avg":-6.564203,"sd":4.26405,"marketCap":86951740},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-01","current":-3.687312,"twenty":-11.1077,"median":-7.894967,"eighty":-1.793992,"marketCap":86951740}],"updateTime":1764677312727},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1803540075,"yearFounded":2002,"employeeNum":8,"address":"4020 Stirrup Creek Drive,Suite 110,Durham,North Carolina,United States","zipCode":"27703","officePhone":"877 265 8266"},"stockCompanyDetail":{"websiteUrl":"http://www.chromocell.com","stockEarnings":[{"period":"1week","weight":-0.0389},{"period":"1month","weight":-0.1982},{"period":"3month","weight":0.1781},{"period":"6month","weight":1.45},{"period":"1year","weight":3.3306},{"period":"ytd","weight":3.1279}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":-0.0026},{"period":"3month","weight":0.0625},{"period":"6month","weight":0.1415},{"period":"1year","weight":0.129},{"period":"ytd","weight":0.1607}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.","exchange":"AMEX","name":"PELTHOS THERAPEUTICS INC","nameEN":"PELTHOS THERAPEUTICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":{"directors":[{"name":"Peter Greenleaf","position":"Chairman of the Board and Director"},{"name":"Scott M. Plesha","position":"Director,Chief Executive Officer and President"},{"name":"Ezra Friedberg","position":"Director"},{"name":"Matthew Pauls","position":"Director"},{"name":"Richard Baxter","position":"Director"},{"name":"Richard Malamut","position":"Director"},{"name":"Todd Davis","position":"Director"}],"executives":[{"name":"Scott M. Plesha","position":"Director,Chief Executive Officer and President"},{"name":"Francis Knuettel II","position":"Chief Financial Officer, Secretary and Treasurer"},{"name":"Sai Rangarao","position":"Chief Commercial Officer"}]}}}